| [1] |
Laimon DN, Sakr DH, Atef B, Shaaban Y. 2024. Highlights of ophthalmological manifestations in newly diagnosed acute leukemia: a correlation with hematological parameters. |
| [2] |
Cicinelli MV, Mastaglio S, Menean M, Marchese A, Miserocchi E, et al. 2022. Retinal microvascular changes in patients with acute leukemia. |
| [3] |
Yassin MA, Ata F, Mohamed SF, Alkhateeb A, Naeem U, et al. 2022. Ophthalmologic manifestations as the initial presentation of chronic myeloid leukemia: a review. |
| [4] |
Lin L, Hu K. 2023. Macrophage function modulated by tPA signaling in mouse experimental kidney disease models. |
| [5] |
Chuang CC, Chen SN. 2016. Induction of posterior vitreous detachment in pediatric vitrectomy by preoperative intravitreal injection of tissue plasminogen activator. |
| [6] |
Hussain RN, Stappler T, Hiscott P, Wong D. 2020. Histopathological changes and clinical outcomes following intervention for sub-internal limiting membrane haemorrhage. |
| [7] |
Rickmann A, Paez LR, della Volpe Waizel M, Bisorca-Gassendorf L, Schulz A, et al. 2021. Functional and structural outcome after vitrectomy combined with subretinal rtPA injection with or without additional intravitreal Bevacizumab injection for submacular hemorrhages. |
| [8] |
Kudo T, Suzuki Y, Metoki T, Nakazawa M. 2015. A case of childhood vitrectomy performed for dense vitreous hemorrhage secondary to leukemia therapy and tumor lysis syndrome. |
| [9] |
Chawla R, Kumar S, Kumawat D, Azad SV, Temkar S, et al. 2021. Chronic myeloid leukaemia accelerates proliferative retinopathy in patients with co-existent diabetes: A risk factor not to be ignored. |
| [10] |
Fung AT, Galvin J, Tran T. 2021. Epiretinal membrane: a review. |